Stocks · Healthcare · Medical - Instruments & Supplies
Pro-Dex, Inc. PDEX
$64.07 -1.97% Close, Oct 2, 2026 · NASDAQ · Market cap $204.6M
Inexpensive vs sector
Next earnings report: Oct 29, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $4.12, up 52.6% year over year.
- Over the past year the stock returned +89.6%, ahead of the S&P 500 by 74.5 percentage points.
- The stock is in an uptrend: above its 200-day average for 155 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 37%
- EPS growth (TTM, YoY)Top 27%
- Revenue growth, 3-year CAGRTop 32%
- Revenue growth accelerationTop 44%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 8%
- Gross marginBottom 20%
- Operating marginTop 16%
- Cash conversion (OCF / net income)Bottom 14%
- Accruals (lower is better)Bottom 8%
- Net debt / EBITDA (lower is better)Top 42%
- Interest coverTop 10%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 7%
- Free-cash-flow yieldTop 24%
- EBITDA / enterprise valueTop 10%
- Sales / enterprise valueTop 36%
- P/E vs own 5-year history (lower is better)Top 48%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 22%
- 6-month returnTop 36%
- 1-year return vs S&P 500Top 17%
- Distance from 52-week highTop 26%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 9%
- Consecutive EPS beatsTop 19%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 33%
- Maximum drawdown, 3 yearsTop 42%
- Beta vs S&P 500 (lower is better)Top 11%
- Net debt / EBITDA (lower is better)Top 42%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 16.4% | 16.4% | ↑ |
| EPS growth (YoY) | 29.3% | 52.6% | ↑ |
| Gross margin | 29.3% | 31.4% | ↑ |
| Operating margin | 16.1% | 16.8% | ↑ |
| FCF margin | -4.4% | 8.9% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 16.4% | 16.4% | ↑ | Top 37% |
| EPS growth (TTM, YoY) | 52.6% | 29.3% | ↑ | Top 27% |
| Gross margin | 31.4% | 29.3% | ↑ | Bottom 20% |
| Operating margin | 16.8% | 16.1% | ↑ | Top 16% |
| Net margin | 17.6% | 13.5% | ↑ | — |
| Free-cash-flow margin | 8.9% | -4.4% | ↑ | — |
| Return on invested capital | 15.0% | — | Top 8% | |
| Revenue growth, 3-year CAGR | 18.9% | — | Top 32% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 0.53×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 8.6%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.9%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +4.8 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 0.50×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 16.0×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 1.66%
- Shareholder yield
- 1.66%
- Share count change, 1 year
- -1.0%
- Share count change, 3-year CAGR
- -2.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Sep 3, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 4
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +78.8%
- Average 2-day reaction, last 8
- +2.6%
- Positive 20 days after report
- 5 of 8
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Sep 3, 2026 | +29.9% | -1.3% | -4.4% | +4.4% | — |
| Apr 30, 2026 | +93.5% | +0.6% | +17.4% | +35.4% | +14.9% |
| Jan 29, 2026 | +11.9% | -0.0% | -0.3% | +13.3% | +32.2% |
| Oct 30, 2025 | +180.0% | -0.3% | +5.3% | +19.7% | +34.3% |
| Sep 3, 2025 | -23.4% | +0.9% | -21.0% | -26.5% | -20.9% |
| May 1, 2025 | +108.5% | +2.5% | -35.0% | -38.6% | -18.5% |
| Jan 30, 2025 | +60.5% | -0.7% | -24.9% | -22.0% | +50.0% |
| Nov 1, 2024 | +158.6% | +19.1% | +32.5% | +64.4% | +38.5% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Sep 3, 2026 | $0.87 | $0.67 | +29.9% | $20.4M |
| Apr 30, 2026 | $1.20 | $0.62 | +93.5% | $19.9M |
| Jan 29, 2026 | $0.66 | $0.59 | +11.9% | $18.7M |
| Oct 30, 2025 | $1.40 | $0.50 | +180.0% | $18.5M |
| Sep 3, 2025 | $0.36 | $0.47 | -23.4% | $17.5M |
| May 1, 2025 | $0.98 | $0.47 | +108.5% | $17.4M |
| Jan 30, 2025 | $0.61 | $0.38 | +60.5% | $16.8M |
| Nov 1, 2024 | $0.75 | $0.29 | +158.6% | $14.9M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 15.6× | 16.8× | 43th | Top 7% |
| P/E (forward) | 20.7× | — | — | — |
| EV / EBITDA | 10.7× | — | — | Top 10% |
| EV / Sales | 2.77× | — | — | Top 36% |
| Free-cash-flow yield | 3.37% | — | — | Top 24% |
| Earnings yield | 6.43% | — | — | Top 7% |
P/E over the past five years
Range 7.4× – 35.9× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +89.6%
- Earnings per share growth (TTM)
- +52.6%
- Change in P/E multiple
- -11.5%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 155
- 50-day average slope (20 days)
- +6.1%
- 200-day average slope (20 days)
- +6.1%
- Distance from 50-day average
- -2.3%
- Distance from 200-day average
- +17.6%
- RSI (14)
- 42.5
- Relative volume
- 0.44×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 66.1%
- Volatility vs own 5-year history
- 68th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.38
- Correlation with S&P 500
- 0.08
- Current drawdown from 1-year high
- -12.7%
- Maximum drawdown, 3 years
- -65.3%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Dec 18, 2020 | May 9, 2022 | -69.1% | 348 days | 628 days (Nov 6, 2024) |
| Apr 28, 2025 | Oct 16, 2025 | -65.3% | 119 days | 222 days (Sep 4, 2026) |
| Jan 6, 2025 | Feb 21, 2025 | -44.6% | 31 days | 33 days (Apr 9, 2025) |
| Sep 4, 2026 | Sep 10, 2026 | -18.5% | 3 days | Not yet recovered |
| Nov 12, 2024 | Nov 18, 2024 | -15.3% | 4 days | 6 days (Nov 26, 2024) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $204.6M
- P/E (TTM)
- 15.6
- EPS, diluted (TTM)
- $4.12
- Revenue (TTM)
- $77.5M
- 52-week range
- $23.47 – $77.00
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Revenue | $42.0M | $46.1M | $53.8M | $66.6M | $77.5M |
| Gross profit | $13.1M | $12.7M | $14.6M | $19.5M | $24.3M |
| Operating income | $5.1M | $5.8M | $7.2M | $10.7M | $13.0M |
| Net income | $4.6M | $7.1M | $2.1M | $9.0M | $13.7M |
| EPS (diluted) | $1.21 | $1.95 | $0.60 | $2.67 | $4.12 |
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | Q4 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.9M | $16.8M | $17.4M | $17.5M | $18.5M | $18.7M | $19.9M | $20.4M |
| Net income | $2.5M | $2.0M | $3.3M | $1.2M | $4.7M | $2.2M | $3.9M | $2.9M |
| EPS (diluted) | $0.75 | $0.61 | $0.98 | $0.36 | $1.40 | $0.66 | $1.20 | $0.86 |
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Operating cash flow | -$847,000 | $5.5M | $6.2M | -$1.7M | $7.2M |
| Capital expenditure | -$1.7M | -$974,000 | -$983,000 | -$1.2M | -$483,000 |
| Free cash flow | -$2.5M | $4.5M | $5.2M | -$2.9M | $6.8M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$1.6M | -$1.5M | -$3.5M | -$3.5M | -$3.3M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $9.3M
- Total assets
- $74.5M
- Total liabilities
- $26.9M
- Total debt
- $18.1M
- Net debt
- $9.9M
- Shareholders’ equity
- $47.6M
As of Jun 30, 2026 (filed Sep 3, 2026).
Short interest
- Shares sold short
- 209,908
- Days to cover
- 2.29
- Change vs previous report
- +17.4%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jun 18, 2010
- 1-for-3